Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction

Backgroud: Myocardial fibrosis results in myocardial remodelling and dysfunction. Celastrol, a traditional oriental medicine, has been suggested to have cardioprotective effects. However, its underlying mechanism is unknown. This study investigated the ability of celastrol to prevent cardiac fibrosi...

Full description

Bibliographic Details
Main Authors: Mian Cheng, Gang Wu, Yue Song, Lin Wang, Ling Tu, Lizhi Zhang, Cuntai Zhang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-05-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/445554
_version_ 1818887928213929984
author Mian Cheng
Gang Wu
Yue Song
Lin Wang
Ling Tu
Lizhi Zhang
Cuntai Zhang
author_facet Mian Cheng
Gang Wu
Yue Song
Lin Wang
Ling Tu
Lizhi Zhang
Cuntai Zhang
author_sort Mian Cheng
collection DOAJ
description Backgroud: Myocardial fibrosis results in myocardial remodelling and dysfunction. Celastrol, a traditional oriental medicine, has been suggested to have cardioprotective effects. However, its underlying mechanism is unknown. This study investigated the ability of celastrol to prevent cardiac fibrosis and dysfunction and explored the underlying mechanisms. Methods: Animal and cell models of cardiac fibrosis were used in this study. Myocardial fibrosis was induced by transverse aortic constriction (TAC) in mice. Cardiac hypertrophy and fibrosis were evaluated based on histological and biochemical measurements. Cardiac function was evaluated by echocardiography. The levels of transforming growth factor beta 1 (TGF-β1), extracellular signal regulated kinases 1/2 (ERK1/2) signalling were measured using Western blotting, while the expression of miR-21was analyzed by real-time qRT-PCR in vitro and in vivo. In vitro studies, cultured cardiac fibroblasts (CFs) were treated with TGF-β1 and transfected with microRNA-21(miR21). Results: Celastrol treatment reduced the increased collagen deposition and down-regulated α-smooth muscle actin (α-SMA), atrial natriuretic peptide (ANP), brain natriuretic peptides (BNP), beta-myosin heavy chain (β-MHC), miR-21 and p-ERK/ERK. Cardiac dysfunction was significantly attenuated by celastrol treatment in the TAC mice model. Celastrol treatment reduced myocardial fibroblast viability and collagen content and down-regulated α-SMA in cultured CFs in vitro. Celastrol also inhibited the miR-21/ERK signalling pathway. Celastrol attenuated miR-21 up-regulation by TGF-β1 and decreased elevated p-ERK/ERK levels in CFs transfected with miR-21. Conclusion: MiR-21/ERK signalling could be a potential therapeutic pathway for the prevention of myocardial fibrosis. Celastrol ameliorates myocardial fibrosis and cardiac dysfunction, these probably related to miR-21/ERK signaling pathways in vitro and in vivo.
first_indexed 2024-12-19T16:45:01Z
format Article
id doaj.art-34b96c3934c7432c8f18ead59bf45e91
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-19T16:45:01Z
publishDate 2016-05-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-34b96c3934c7432c8f18ead59bf45e912022-12-21T20:13:41ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782016-05-013851928193810.1159/000445554445554Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and DysfunctionMian ChengGang WuYue SongLin WangLing TuLizhi ZhangCuntai ZhangBackgroud: Myocardial fibrosis results in myocardial remodelling and dysfunction. Celastrol, a traditional oriental medicine, has been suggested to have cardioprotective effects. However, its underlying mechanism is unknown. This study investigated the ability of celastrol to prevent cardiac fibrosis and dysfunction and explored the underlying mechanisms. Methods: Animal and cell models of cardiac fibrosis were used in this study. Myocardial fibrosis was induced by transverse aortic constriction (TAC) in mice. Cardiac hypertrophy and fibrosis were evaluated based on histological and biochemical measurements. Cardiac function was evaluated by echocardiography. The levels of transforming growth factor beta 1 (TGF-β1), extracellular signal regulated kinases 1/2 (ERK1/2) signalling were measured using Western blotting, while the expression of miR-21was analyzed by real-time qRT-PCR in vitro and in vivo. In vitro studies, cultured cardiac fibroblasts (CFs) were treated with TGF-β1 and transfected with microRNA-21(miR21). Results: Celastrol treatment reduced the increased collagen deposition and down-regulated α-smooth muscle actin (α-SMA), atrial natriuretic peptide (ANP), brain natriuretic peptides (BNP), beta-myosin heavy chain (β-MHC), miR-21 and p-ERK/ERK. Cardiac dysfunction was significantly attenuated by celastrol treatment in the TAC mice model. Celastrol treatment reduced myocardial fibroblast viability and collagen content and down-regulated α-SMA in cultured CFs in vitro. Celastrol also inhibited the miR-21/ERK signalling pathway. Celastrol attenuated miR-21 up-regulation by TGF-β1 and decreased elevated p-ERK/ERK levels in CFs transfected with miR-21. Conclusion: MiR-21/ERK signalling could be a potential therapeutic pathway for the prevention of myocardial fibrosis. Celastrol ameliorates myocardial fibrosis and cardiac dysfunction, these probably related to miR-21/ERK signaling pathways in vitro and in vivo.http://www.karger.com/Article/FullText/445554Micro RNA-21CelastrolERKMyocardial fibrosis
spellingShingle Mian Cheng
Gang Wu
Yue Song
Lin Wang
Ling Tu
Lizhi Zhang
Cuntai Zhang
Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
Cellular Physiology and Biochemistry
Micro RNA-21
Celastrol
ERK
Myocardial fibrosis
title Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
title_full Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
title_fullStr Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
title_full_unstemmed Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
title_short Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction
title_sort celastrol induced suppression of the mir 21 erk signalling pathway attenuates cardiac fibrosis and dysfunction
topic Micro RNA-21
Celastrol
ERK
Myocardial fibrosis
url http://www.karger.com/Article/FullText/445554
work_keys_str_mv AT miancheng celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction
AT gangwu celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction
AT yuesong celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction
AT linwang celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction
AT lingtu celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction
AT lizhizhang celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction
AT cuntaizhang celastrolinducedsuppressionofthemir21erksignallingpathwayattenuatescardiacfibrosisanddysfunction